BioSpace News Archive

AbCellera (Nasdaq: ABCL) today announced a CA$701 million co-investment with the Governments of Canada and British Columbia to build new capabilities and infrastructure to develop innovative antibody-based medicines and strengthen Canada’s leadership in clinical research, manufacturing, and drug development.

Pluton Biosciences, a startup leveraging the power of microbes to create cost-effective innovative solutions that address sustainability challenges facing agriculture, announces the close of a $16.5 M Series A funding round.

Scientists at Klick Labs have developed a new way to catch the earliest signs the human body is failing to control blood glucose levels, before it reaches prediabetic levels in patients.

Reveal Lasers LLC, a leading provider of energy-based devices, is proud to announce today the launch of Eterna - an FDA-cleared radiofrequency device that reduces fine lines and wrinkles, tightens skin through soft tissue coagulation and does not require consumables.

Revolution Medicines, Inc. announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker in a fireside chat at the TD Cowen 4th Annual Oncology Innovation Summit.

NeuroPace, Inc. announced the appointment of Ms. Kelley Nicholas as Vice President of Sales effective May 22, 2023.

Annexon, Inc. announced topline results from its ARCHER Phase 2 trial of ANX007 in patients with geographic atrophy, the leading cause of blindness worldwide, demonstrating a statistically significant, dose-dependent preservation of visual function.

10x Genomics, Inc., a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist Gene and Protein Expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities.

Spruce Biosciences, Inc. announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the Jefferies Healthcare Conference on June 9, 2023, at 9:30 a.m. ET.

IVERIC bio, Inc. reported that on May 19, 2023, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 63 newly-hired, non-executive employees.